PLEASE NOTE While the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of CKD remains the current global standard, a focused update to “Chapter 3: Delaying CKD progression and managing its complications” is currently underway to address emerging evidence on SGLT2 inhibitors, GLP-1-based therapies, and nonsteroidal mineralocorticoid receptor antagonists in people with CKD … Continue reading CKD Evaluation and Management